Aspirin as a Therapeutic Agent in Cardiovascular Disease
- 21 October 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 96 (8) , 2751-2753
- https://doi.org/10.1161/01.cir.96.8.2751
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Aspirin in the Treatment of Acute Myocardial Infarction in Elderly Medicare BeneficiariesCirculation, 1995
- Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction.Circulation, 1994
- Collaborative overview of randomised trials of antiplatelet therapy - III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patientsBMJ, 1994
- Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.Circulation, 1989
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim resultsBMJ, 1988
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971